China Universal Asset Management »

Atea Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $65k 16k 4.02
2023-12-31 $29k 9.7k 3.00
2023-09-30 $6.0k 2.1k 2.81
2023-06-30 $4.0k 1.1k 3.66
2023-03-31 $4.0k 1.1k 3.54
2022-12-31 $4.0k 846 4.73
2022-09-30 $4.0k 780 5.13

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Atea Pharmaceuticals

BlackRock
EcoR1 Capital
BML Capital Management
Vanguard Group
Tang Capital Management
Acadian Asset Management
Charles Schwab Investment Management
Federated Investors
Jacobs Levy Equity Management
Newtyn Management
Susquehanna International
Dimensional Fund Advisors
Banque Pictet & Cie Sa
Two Sigma Advisers
CM Management

View all funds holding Atea Pharmaceuticals